Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Johnson and Johnson
Cantor Fitzgerald
Fuji
McKinsey
US Army
Boehringer Ingelheim
Mallinckrodt
Citi
Farmers Insurance

Generated: August 19, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076477

« Back to Dashboard
NDA 076477 describes ATORVASTATIN CALCIUM, which is a drug marketed by Teva Pharms Usa, Sciegen Pharms Inc, Kremers Urban Pharms, Mylan Pharms Inc, Invagen Pharms, Apotex Inc, Dr Reddys Labs Ltd, Teva Pharms, Sandoz Inc, and Sun Pharm Inds Ltd, and is included in eleven NDAs. It is available from fifty suppliers. Additional details are available on the ATORVASTATIN CALCIUM profile page.

The generic ingredient in ATORVASTATIN CALCIUM is atorvastatin calcium. There are sixty-one drug master file entries for this compound. Fifty-eight suppliers are listed for this compound. Additional details are available on the atorvastatin calcium profile page.

Summary for NDA: 076477

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 076477

Suppliers and Packaging for NDA: 076477

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ATORVASTATIN CALCIUM
atorvastatin calcium
TABLET;ORAL 076477 ANDA Aidarex Pharmaceuticals LLC 33261-972 33261-972-30 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (33261-972-30)
ATORVASTATIN CALCIUM
atorvastatin calcium
TABLET;ORAL 076477 ANDA Aidarex Pharmaceuticals LLC 33261-972 33261-972-90 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (33261-972-90)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 10MG BASE
Approval Date:Nov 30, 2011TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 20MG BASE
Approval Date:Nov 30, 2011TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 40MG BASE
Approval Date:Nov 30, 2011TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Merck
Citi
US Army
Healthtrust
Novartis
Baxter
Dow
UBS
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot